My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Gaviscon Liquid-Aniseed Flavour, Oral Suspension Each 10 ml contains: Sodium alginate 500 mg Sodium bicarbonate 267 mg Calcium carbonate 160 mg



Reckitt Benckiser Ireland LtdPA0979/015/003

Main Information

Trade NameGaviscon Liquid-Aniseed Flavour, Oral Suspension Each 10 ml contains: Sodium alginate 500 mg Sodium bicarbonate 267 mg Calcium carbonate 160 mg
Active SubstancesSodium bicarbonate
Calcium carbonate
Sodium alginate
Dosage FormOral suspension
Licence HolderReckitt Benckiser Ireland Ltd
Licence NumberPA0979/015/003

Group Information

ATC CodeA02AX Antacids, other combinations
A02AX13 Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)

Status

License statusAuthorised
Licence Issued29/06/2001
Legal statusProduct not subject to medical prescription
Supply StatusSupply through non-pharmacy outlets and pharmacies
Advertising StatusAdvertising to the general public
Conditions of LicenceRetail sale through pharmacies only. General sale: Maximum pack size 300 ml.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print